|
Study | Model | Ischemic Protocol | Duration/onset of diabetes | Substrates | Model of diabetes | End points |
|
Hadour et al. (1998) [48] | Rabbit, alloxan (100 mg/kg) | In vivo nonrecovery, 30 min regional ischemia/3 hr reperfusion | 2 months | In vivo substrates | Type I diabetes | Infarction |
|
Schaffer et al. (2000) [49] | Rat, neonatal cardiomyocytes | 10 mM deoxyglucose and and 3 mM amobarbital medium for 1 hr, OR hypoxic chamber: 2.3% O2–5% CO2-balance N2 for 1 hr | 3-day incubation with 25 mM glucose in medium | — | Type I diabetes | Infarction |
|
Oliveria et al. (2001) [50] | Goto Kakizaki Rat, male, isolated cardiomyocyte mitochondria | — | In-bred strain | — | Type II diabetes | Cell death and mPTP |
|
Nawata et al. (2002) [51] | Rat, STZ (65 mg/kg) | Langendorff isolated heart, 30 min low flow global ischemia/30 min reperfusion | 4 weeks | 11 mmol/L glucose | Type I diabetes | Myocardial function |
|
Ooie et al. (2003) [52] | Rat, STZ (65 mg/kg) | Langendorff isolated heart: Low-flow global ischemia for 5 min, followed by no-flow ischemia for 25 min. 30 min reperfusion | 12 weeks | 11 mmol/L glucose | Type I diabetes | Myocardial function, creatine kinase release |
|
Ravingerová et al. (2003) [53] | Rat, STZ (45 mg/kg) | In vivo non recovery, 30 min regional ischemia/4 hr reperfusion | 1 week | In vivo substrates | Type I diabetes | Infarction |
|
Kristiansen et al. (2004) [54] | Goto Kakizaki Rat, male | Langendorff isolated heart, 50 min regional ischemia/2 hr reperfusion | In-bred strain | 11 mmol/L glucose | Type II diabetes | Infarction |
|
Kristiansen et al. (2004) [54] | Obese Zucker Diabetic Fatty Rat, male | Langendorff isolated heart, 50 min regional ischemia/2 hr reperfusion | In-bred strain | 11 mmol/L glucose | Type II diabetes | Infarction |
|
Tsang et al. (2005) [55] | Goto Kakizaki Rat, male | Langendorff isolated heart, 30 min regional ischemia/2 hr reperfusion | In-bred strain | 11 mmol/L glucose | Type II diabetes | Infarction, kinase expression |
|
Ma et al. (2006) [56] | Rat, STZ (50 mg/kg) | In vivo non recovery, 30 min regional ischemia/2 hr reperfusion | 2 weeks | In vivo substrates | Type I diabetes | Infarction |
|
Chu et al. (2010) [57] | Yucatan pigs, alloxan (200 mg/kg) | In vivo non recovery, 1 hr regional ischemia/2 hr reperfusion | 5 weeks | In vivo substrates | Type I diabetes | Infarction and protein expression |
|
Shi-Ting et al. (2010) [58] | Rat, STZ (60 mg/kg) | Langendorff isolated heart, 30 min regional ischemia/40 min reperfusion | 4 weeks | 11 mmol/L glucose | Type I diabetes | Infarction and creatine kinase release |
|